当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
MenQuadfi, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine
药品名称
MenQuadfi, Meningococcal (Groups A, C, Y, W) Conjugate Vaccine
承诺描述
Deferred pediatric study (MET41) under PREA to evaluate the safety of MenQuadfi in infants and toddlers 6 weeks through 12 months of age.